YmAbs snags $50 mln
Y-mAbs Therapeutics Inc, a New York City and Denmark-based developer of cancer treatments, has raised $50 million in funding. The investors included HBM Healthcare Investments.
26 October 2017•1 min read
Y-mAbs Therapeutics Inc, a New York City and Denmark-based developer of cancer treatments, has raised $50 million in funding. The investors included HBM Healthcare Investments.
